You have 9 free searches left this month | for more free features.

Fluorouracil

Showing 51 - 75 of 2,922

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Bladder Cancer Trial in Canada, United States (drug, radiation, procedure)

Completed
  • Bladder Cancer
  • induction cisplatin
  • +13 more
  • Atlanta, Georgia
  • +10 more
May 23, 2022

Stage III Hepatocellular Carcinoma AJCC v8, Stage IIIA Hepatocellular Carcinoma AJCC v8, Stage IIIB Hepatocellular Carcinoma

Recruiting
  • Stage III Hepatocellular Carcinoma AJCC v8
  • +6 more
  • Fluorouracil
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Nov 18, 2021

Advanced/Metastatic Colorectal Cancer Trial in Guangzhou (Dalpiciclib, Oxaliplatin injection, Calcium folinate)

Not yet recruiting
  • Advanced/Metastatic Colorectal Cancer
  • Guangzhou, Guangdong, China
    Sixth Affiliated Hospital, Sun Yat-sen University
Jul 28, 2022

Biliary Tract Cancer Trial in United States (Nivolumab, Nanoliposomal-Irinotecan, 5-Fluorouracil)

Active, not recruiting
  • Biliary Tract Cancer
  • Ann Arbor, Michigan
  • +4 more
Oct 6, 2022

Colorectal Cancer Trial (mFOLFOXIRI, mFOLFOX6)

Not yet recruiting
  • Colorectal Cancer
  • (no location specified)
Jun 17, 2022

Oral Squamous Cell Carcinoma, Neoadjvant Therapy, Anti-PD-1 Trial in Shanghai (Toripalimab (anti-programmed death-1 inhibitor),

Recruiting
  • Oral Squamous Cell Carcinoma
  • +3 more
  • Toripalimab (anti-programmed death-1 inhibitor)
  • +4 more
  • Shanghai, Shanghai, China
    Ninth People's Hospital, Shanghai Jiao Tong University School of
Oct 8, 2022

Pancreatic Cancer Trial in Nanjing (Cadonilimab+mFOLFIRINOX)

Not yet recruiting
  • Pancreatic Cancer
  • Nanjing, Jiangsu, China
    The First Affiliated Hospital with Nanjing Medical University
Nov 23, 2023

Colorectal Cancer Trial in Philadelphia (Regorafenib, 5-FU, Leucovorin)

Terminated
  • Colorectal Cancer
  • Philadelphia, Pennsylvania
    Fox Chase Cancer Center
Jan 10, 2022

Gastric Cancer, Stomach Cancer, GastroEsophageal Cancer Trial in Kyiv (Docetaxel, Oxaliplatin, Leucovorin)

Recruiting
  • Gastric Cancer
  • +10 more
  • Kyiv, Ukraine
    National Cancer Institute
Aug 31, 2023

Carcinoma, Squamous Cell of Head and Neck Trial in Darmstadt (Cetuximab, Cisplatin/Carboplatin, 5-fluorouracil)

Completed
  • Carcinoma, Squamous Cell of Head and Neck
  • Darmstadt, Germany
    Research site
Apr 19, 2022

Clinical Stage II Esophageal Adenocarcinoma AJCC v8, Clinical Stage III Esophageal Adenocarcinoma AJCC v8, Clinical Stage III

Recruiting
  • Clinical Stage II Esophageal Adenocarcinoma AJCC v8
  • +10 more
  • Biopsy
  • +8 more
  • Buffalo, New York
    Roswell Park Cancer Institute
Jan 20, 2023

Unresectable Locally Advanced, Recurrent or Metastatic Esophageal Squamous Cell Carcinoma Trial in Shanghai (CS1001+

Active, not recruiting
  • Unresectable Locally Advanced, Recurrent or Metastatic Esophageal Squamous Cell Carcinoma
  • CS1001+ Fluorouracil+Cisplatin
  • Placebo+ Fluorouracil+Cisplatin
  • Shanghai, Shanghai, China
    Shanghai East Hospital
Mar 20, 2022

Colorectal Cancer Trial in Guangzhou (mFOLFOXIRI plus Bevacizumab, mFOLFOX6 Plus Bevacizumab)

Recruiting
  • Colorectal Cancer
  • mFOLFOXIRI plus Bevacizumab
  • mFOLFOX6 Plus Bevacizumab
  • Guangzhou, Guangdong, China
    Gastrointestinal Hospital, Sun Yat-sen University
Jun 15, 2022

Colorectal Cancer, Esophagus Cancer, Appendix Cancer Trial (FOX dose-escalation algorithm)

Not yet recruiting
  • Colorectal Cancer
  • +4 more
  • FOX dose-escalation algorithm
  • (no location specified)
Mar 24, 2023

Tumor Neck Trial in Shanghai (docetaxel, cisplatin and 5-fluorouracil)

Recruiting
  • Neoplasm Neck
  • docetaxel, cisplatin and 5-fluorouracil
  • Shanghai, Shanghai, China
    Ninth People's Hospital, School of Medicine, Shanghai Jiao Tong
Oct 5, 2022

Nasopharyngeal Carcinoma, Nasopharyngeal Tumors, Nasopharyngeal Diseases Trial in Guangzhou (gemcitabine and cisplatin,

Recruiting
  • Nasopharyngeal Carcinoma
  • +3 more
  • gemcitabine and cisplatin
  • +3 more
  • Guangzhou, Guangdong, China
    Sun Yat-sen University Cancer Center
May 4, 2022

Advanced Biliary Tract Cancer Trial in Washington, Indianapolis, Saint Louis (Nanoliposomal Irinotecan, Leucovorin,

Recruiting
  • Advanced Biliary Tract Cancer
  • Nanoliposomal Irinotecan
  • +2 more
  • Washington, District of Columbia
  • +2 more
Oct 29, 2021

Borderline Resectable Pancreatic Adenocarcinoma, Locally Advanced Pancreatic Ductal Adenocarcinoma Trial in Los Angeles

Not yet recruiting
  • Borderline Resectable Pancreatic Adenocarcinoma
  • Locally Advanced Pancreatic Ductal Adenocarcinoma
  • Biospecimen Collection
  • +9 more
  • Los Angeles, California
    Yonemoto,Lisa
Jan 13, 2023

Chemo Induced Peripheral Neuropathy Trial (Omeprazole)

Not yet recruiting
  • Chemotherapy Induced Peripheral Neuropathy
  • (no location specified)
Jan 10, 2023

Adenocarcinoma of the Esophagus, Adenocarcinoma of the Gastroesophageal Junction, Adenocarcinoma of the Gastric Cardia Trial in

Active, not recruiting
  • Adenocarcinoma of the Esophagus
  • +5 more
  • Cleveland, Ohio
    Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Ca
Jul 25, 2022

GastroEsophageal Cancer Trial in Boston (Irinotecan, Oxaliplatin, Leucovorin)

Active, not recruiting
  • GastroEsophageal Cancer
  • Boston, Massachusetts
    Massachusetts General Hospital
Sep 7, 2022

Cancer of Pancreas, Chemo Effect, Metastatic Pancreatic Cancer Trial in Shibin Al Kawm (Gemcitabine fluorouracil)

Completed
  • Cancer of Pancreas
  • +2 more
  • Gemcitabine fluorouracil
  • Shibīn Al Kawm, Menoufia, Egypt
    Menoufia University, Faculty of medicine
Aug 5, 2022

Plantar Wart Trial in Sohag (Bleomycin and 5-fluorouracil)

Not yet recruiting
  • Plantar Wart
  • Bleomycin and 5-fluorouracil
  • Sohag, Egypt
    Sohag Faculty of Medicine
Sep 26, 2021

Gastric Adenocarcinoma, Oligometastasis, Stage IV Esophageal Adenocarcinoma AJCC v7 Trial in Houston (drug, procedure,

Recruiting
  • Gastric Adenocarcinoma
  • +4 more
  • Houston, Texas
    M D Anderson Cancer Center
Sep 20, 2022

Cervical Esophagus Adenocarcinoma, Clinical Stage II Esophageal Adenocarcinoma AJCC v8, Clinical Stage IIA Esophageal

Recruiting
  • Cervical Esophagus Adenocarcinoma
  • +12 more
  • Houston, Texas
    M D Anderson Cancer Center
Dec 31, 2022